Researchers at the University of the Witwatersrand (Wits) in South Africa, in collaboration with a theoretical team from Huzhou University…
Read More
Filspari Secures Landmark FDA Approval for Focal Segmental Glomerulosclerosis (FSGS) in Adults and Pediatric Patients Aged Eight and Above
Travere Therapeutics has achieved a significant milestone in the treatment of rare kidney diseases with the U.S. Food and Drug…
Read More
Science News: A Century of Empowering Public Understanding of Science, Medicine, and Technology
Science News, a venerable institution in science journalism, has been dedicated to providing accurate and accessible information on the latest…
Read More
The Unveiling of Cryptic Species: Borneo’s Fanged Frogs Redefine Discovery in the Age of Genomics
When the public imagines the discovery of a new species, the imagery often conjures a dramatic narrative akin to an…
Read More
Breakthrough Human-Only Bone Marrow Model Paves the Way for Advanced Blood Cancer Research and Reduced Animal Testing
In a significant leap for regenerative medicine and hematology, researchers at the University of Basel and University Hospital Basel have…
Read More
OrsoBio’s LXR Inverse Agonist Shows Promise for Hard-to-Treat Triglyceride Disorders, Paving New Path Beyond GLP-1 Dominance
OrsoBio, a specialized biotechnology firm dedicated to pioneering therapies for obesity and its associated metabolic conditions, is strategically charting a…
Read More
Breakthrough Gene Therapy Offers Precise Non-Addictive Relief for Chronic Pain by Targeting Brain Circuitry
A landmark preclinical study has unveiled a novel gene therapy designed to neutralize chronic pain at its source within the…
Read More
New York University Researchers Develop Macro-Scale Sound-Levitated Time Crystal Challenging Traditional Laws of Motion
Physicists at New York University’s Center for Soft Matter Research have announced the creation of a novel form of matter—a…
Read More
FDA Issues Complete Response Letter to Replimune’s RP1 for Advanced Melanoma
The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding Replimune Group’s Biologics License Application…
Read More
Optovolution: Harnessing Light to Engineer Dynamic Proteins for Advanced Biological Engineering
Evolution, the relentless engine of biological innovation, has long been nature’s most sophisticated engineering process. Within the microscopic world of…
Read More
